These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 12481194

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R, Niizawa S, Koike K, Sagara T, Kanematsu K, Takayanagi I.
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Opioid receptor interaction and adenylyl cyclase inhibition of dihydroetorphine: direct comparison with etorphine.
    Niwa M, al-Essa LY, Ohta S, Kohno K, Nozaki M, Tsurumi K, Iwamura T, Kataoka T.
    Life Sci; 1995; 56(21):PL395-400. PubMed ID: 7739347
    [Abstract] [Full Text] [Related]

  • 26. Antinociceptive effect of dihydroetorphine and its tolerance/dependence liability in mice.
    Tokuyama S, Takahashi M, Kaneto H.
    Biol Pharm Bull; 1993 Aug; 16(8):774-7. PubMed ID: 8220323
    [Abstract] [Full Text] [Related]

  • 27. Antinociceptive effect of dihydroetorphine in diabetic mice.
    Kamei J, Suzuki T, Misawa M, Nagase H, Kasuya Y.
    Eur J Pharmacol; 1995 Feb 24; 275(1):109-13. PubMed ID: 7774657
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Etorphines: mu-opioid receptor-selective antinociception and low physical dependence capacity.
    Aceto MD, Harris LS, Bowman ER.
    Eur J Pharmacol; 1997 Nov 12; 338(3):215-23. PubMed ID: 9424015
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors.
    Xu H, Wang X, Partilla JS, Bishop-Mathis K, Benaderet TS, Dersch CM, Simpson DS, Prisinzano TE, Rothman RB.
    Brain Res Bull; 2008 Sep 05; 77(1):49-54. PubMed ID: 18639745
    [Abstract] [Full Text] [Related]

  • 33. Intracerebroventricular administration of CYX-6, a potent μ-opioid receptor agonist, a δ- and κ-opioid receptor antagonist and a biased ligand at μ, δ & κ-opioid receptors, evokes antinociception with minimal constipation and respiratory depression in rats in contrast to morphine.
    Imam MZ, Kuo A, Ghassabian S, Cai Y, Qin Y, Li T, Smith MT.
    Eur J Pharmacol; 2020 Mar 15; 871():172918. PubMed ID: 31958457
    [Abstract] [Full Text] [Related]

  • 34. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM, Li QL, Zhang CF, Xu XJ, Chen J, Ju YW, Chi ZQ, Long YQ, Liu JG.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):306-11. PubMed ID: 18353307
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.
    Schmidt BL, Tambeli CH, Levine JD, Gear RW.
    Eur J Neurosci; 2002 Mar 28; 15(5):861-8. PubMed ID: 11906528
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.